Bright Minds Biosciences Inc (DRUG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 20 | 20 | 17 | 16 | 22 |
| Accounts receivable | -696 | -31 | -140 | -39 | -167 |
| Other Working Capital | 1,409 | -996 | 1,192 | -379 | -139 |
| Other Operating Activity | -9,978 | -4,809 | -2,336 | -3,101 | -2,143 |
| Operating Cash Flow | $-9,246 | $-5,816 | $-1,268 | $-3,504 | $-2,425 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -26 | -26 | -26 | -26 | -25 |
| Common Stock Issued | 243,249 | 13,944 | 33,469 | 0 | 0 |
| Other Financing Activity | -14,756 | -527 | -124 | 9 | 250 |
| Financing Cash Flow | $228,467 | $13,391 | $33,318 | $-17 | $225 |
| Exchange Rate Effect | 1,423 | -1,436 | -529 | -772 | -17 |
| Beginning Cash Position | 89,048 | 82,909 | 51,388 | 55,680 | 57,897 |
| End Cash Position | 309,692 | 89,048 | 82,909 | 51,388 | 55,680 |
| Net Cash Flow | $219,221 | $7,575 | $32,050 | $-3,521 | $-2,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,246 | -5,816 | -1,268 | -3,504 | -2,425 |
| Free Cash Flow | -9,246 | -5,816 | -1,268 | -3,504 | -2,425 |